Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Huifeng Gao"'
Publikováno v:
Biology Direct, Vol 19, Iss 1, Pp 1-14 (2024)
Abstract Background Excavation of key molecules can help identify therapeutic targets and improve the prognosis of pancreatic cancer. This study evaluated the roles of SUMO3 in cell viability, glycolysis, gemcitabine (GEM) sensitivity, and the antitu
Externí odkaz:
https://doaj.org/article/a62c502c08cf401997b06443591c7b14
Publikováno v:
Cell & Bioscience, Vol 10, Iss 1, Pp 1-10 (2020)
Abstract Background Human pyruvate dehydrogenase phosphatase 1 (PDP1) plays an important physiological role in energy metabolism; however, its expression and function in human pancreatic adenocarcinoma (PDAC) remain unknown. This study aimed to inves
Externí odkaz:
https://doaj.org/article/24d15742c14749d884d9739991dcce81
Autor:
Chien-shan Cheng, Jiaqiang Wang, Jie Chen, Kuei Ting Kuo, Jian Tang, Huifeng Gao, Lianyu Chen, Zhen Chen, Zhiqiang Meng
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-27 (2019)
Abstract Aim of the review In the past decade, increasing research attention investigated the novel therapeutic potential of steroidal cardiac glycosides in cancer treatment. Huachansu and its main active constituent Bufalin have been studied in vitr
Externí odkaz:
https://doaj.org/article/57155f281ff74249a8f39a22c0896ba9
Publikováno v:
Evidence-Based Complementary and Alternative Medicine. 2022:1-10
While randomized controlled trials (RCTs) are the gold standard for evidence-based medicine, they do not always reflect the real condition of patients in the real-world setting, which limits their generalizability and external validity. Real-world ev
Publikováno v:
Journal of Inflammation Research.
Yujie Li,1,2 Linjia Peng,1,2 Ke Zhang,1,2 Yong Wu,3 Huifeng Gao,1,2 Hao Chen1,2 1Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, Peopleâs Republic of China; 2Department of Oncology, Shanghai Medical College
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 18; Pages: 10231
Pancreatic adenocarcinoma (PAAD) is a highly heterogeneous and immunosuppressive cancer. This study investigated the diversity of DNA damage repair (DDR) and immune microenvironment in PAAD by transcriptomic and genomic analysis. Patients with PAAD w
Publikováno v:
OncoTargets and Therapy. 13:389-399
Objective Rho GTPase-activating protein 4 (ARHGAP4) is a GTPase-activating protein for the small GTPases of the Rho family that is involved in tumorigenesis. We recently reported that ARHGAP4 can mediate Warburg effect and malignant phenotype of panc
Autor:
Hao Chen, Zhiqiang Meng, Jian Tang, Lianyu Chen, Ye Li, Chien-Shan Cheng, Zhen Chen, Huifeng Gao
Publikováno v:
Aging (Albany NY)
Chemokines play essential roles in the progression of various human cancers; however, the expression and role of CXC chemokines in pancreatic adenocarcinoma (PAAD) have not yet been identified. The aim of this study is to identify the expression patt
Autor:
Jian Tang, Zhen Chen, Chien-Shan Cheng, Zhiqiang Meng, Lianyu Chen, Jie Chen, Kuei Ting Kuo, Jiaqiang Wang, Huifeng Gao
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-27 (2019)
Cancer Cell International
Cancer Cell International
Aim of the review In the past decade, increasing research attention investigated the novel therapeutic potential of steroidal cardiac glycosides in cancer treatment. Huachansu and its main active constituent Bufalin have been studied in vitro, in viv
Publikováno v:
Cancer Management and Research. 11:3171-3185
Background: Accumulating studies have reported that aberrant expression of SLC5A1 is a negative prognostic factor to various cancer patients. Purpose: Pancreatic cancer tissue has also shown to harbor higher expression of SLC5A1, however how SLC5A1 m